Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment

Breast Cancer Research

Volumn 7, Issue 5, 2005, Pages

  Richert, Monica M ^a   Phadke, Pushkar A ^a   Matters, Gail ^b   DiGirolamo, Douglas J ^a   Washington, Sharlene ^b   Demers, Laurence M ^b   Bond, Judith S ^b   Manni, Andrea ^b   Welch, Danny R ^a  

^a University of Alabama at Birmingham   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; MEPRIN; MEPRIN ALPHA; ORNITHINE DECARBOXYLASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; INCIDENCE; LUNG METASTASIS; MDA-MB-231 CELL LINE; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; BONE TUMOR; BREAST TUMOR; FEMALE; LUNG TUMOR; METASTASIS; MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; EFLORNITHINE; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33644877724     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1292     Document Type: Article

References (26)

1. Gerner EW, Meyskens FL: Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004, 4: 781-792 10.1038/nrc1454.
2. Pendeville H, Carpino N, Marine JC, Takahashi Y, Muller M, Martial JA, Cleveland JL: The ornithine decarboxylase gene is essential for cell survival during early murine development. Molec Cell Biol. 2001, 21: 6549-6558 10.1128/MCB.21.19.6549-6558.2001.
3. Manni A, Wechter R, Verderame MF, Mauger D: Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: role of the MAPK pathway. Int J Cancer. 1998, 76: 563-570 10.1002/(SICI)1097-0215(19980518)76:4<563::AID-IJC20>3.0.CO;2-7.
4. Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D, Demers LM: Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Int J Cancer. 1997, 70: 175-182 10.1002/(SICI)1097-0215(19970117)70:2<175::AID-IJC7>3.0.CO;2-U.
5. Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM: Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer. 1987, 60: 2237-2243.
6. Canizares F, Salinas J, de las HM, Diaz J, Tovar I, Martinez P, Penafiel R: Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res. 1999, 5: 2035-2041.
7. Manni A, Mauger D, Gimotty P, Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res. 1996, 2: 1901-1906.
8. Manni A, Washington S, Craig L, Cloud M, Griffith JW, Verderame MF, Texter LJ, Mauger D, Demers LM, Harms JF, et al: Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. Clin Exp Metastasis. 2003, 20: 321-325 10.1023/A:1024055522067.
9. Manni A, Washington S, Griffith JW, Verderame MF, Mauger D, Demers LM, Samant RS, Welch DR: Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells. Clin Exp Metastasis. 2002, 19: 95-105 10.1023/A:1014536909007.
10. Harms JF, Welch DR: MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis. 2003, 20: 327-334 10.1023/A:1024062911144.
11. Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, et al: A small molecule antagonist of the alpha-v, beta-3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis. 2004, 21: 119-128 10.1023/B:CLIN.0000024763.69809.64.
12. Welch DR: Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis. 1997, 15: 272-306 10.1023/A:1018477516367.
13. Manni A, Fischer S, Franks M, Washington S, De AR, Griffith J, Demers L, Verderame M, Leiby B, Mauger D: S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells. Int J Oncol. 2001, 19: 317-323.
14. Guo YJ, Cleveland JL, O'Brien TG: Haploinsufficiency for Odc modifies mouse skin tumor susceptibility. Cancer Res. 2005, 65: 1146-1149.
15. Manni A, Grove R, Kunselman S, Aldaz M: Involvement of the polyamine pathway in breast cancer progression. Cancer Lett. 1995, 92: 49-57 10.1016/0304-3835(95)03763-M.
16. Manni A, Washington S, Mauger D, Hackett DA, Verderame MF: Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells. Clin Exp Metastasis. 2004, 21: 461-467 10.1007/s10585-004-2724-3.
17. Gerner EW, Mamont PS: Restoration of the polyamine contents in rat hepatoma tissue-culture cells after inhibition of polyamine biosynthesis. Relationship with cell proliferation. Eur J Biochem. 1986, 156: 31-35 10.1111/j.1432-1033.1986.tb09544.x.
18. Meyskens FL, Gerner EW, Emerson S, Pelot D, Durbin T, Doyle K, Lagerberg W: Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst. 1998, 90: 1212-1218 10.1093/jnci/90.16.1212.
19. Roodman GD: Mechanisms of disease: mechanisms of bone metastasis. N Engl J Med. 2004, 350: 1655-1664 10.1056/NEJMra030831.
20. Mundy GR: Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002, 2: 584-593 10.1038/nrc867.
21. Kang YB, Siegel PM, Shu WP, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549 10.1016/S1535-6108(03)00132-6.
22. Guise TA: Parathyroid hormone-related protein and bone metastases. Cancer. 1997, 80: 1572-1580 10.1002/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M.
23. Yoneda T, Sasaki A, Mundy GR: Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat. 1994, 32: 73-84 10.1007/BF00666208.
24. Matters GL, Manni A, Bond JS: Inhibitors of polyamine synthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells. Clin Exptl Metastasis.
25. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997, 89: 1260-1270 10.1093/jnci/89.17.1260.
26. Huang Y, Hager ER, Phillips DL, Dunn VR, Hacker A, Frydman B, Kink JA, Valasinas AL, Reddy VK, Marton LJ, et al: A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res. 2003, 9: 2769-2777.